An official website of the United States government
Home
Name
Asparlas
Alternate Names
calaspargase pegol-mknl
Abbreviations
None
Category
Chemotherapy
Subcategory
Antineoplastic agent
NSC Number
None
Primary Site
None
Histology
Remarks
December 20, 2018 FDA approved Asparlas as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia (ALL).
Coding
This drug should be coded
